Skip to main content
    G

    Ginkgo Bioworks Holdings (DNA)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NYSE

    $9.61
    -0.62 (-6.06%)

    Market Cap: $622.97M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Ginkgo Bioworks Holdings (DNA) Government Contracts

    Updated Aug 4, 2026. Contract data from federal award records.

    Federal agencies obligated $26.59M to Ginkgo Bioworks Holdings over the 12 months through Jul 31, 2026, down 60.5% from the prior 12 months. Department of Health and Human Services was the top awarding agency with 95.8% of obligations across 2 agencies. Ginkgo Bioworks Holdings had obligation activity on 4 federal contracts over the same 12 months, including 1 new contract.

    Federal Obligations

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated.

    Obligations
    $26.59M
    Change
    -60.5%
    Obligations to revenue
    17.6%
    Prior 12 months$67.34M
    Contracts with activity4
    New contracts1
    Top agencyDepartment of Health and Human Services
    Top agency share95.8%
    Agencies2
    Average remaining term17.9 months

    12 months through Jul 31, 2026

    Largest New Awards

    Award IDAgencyAmountStartEndDescription
    75D30126F00004Centers for Disease Control and Prevention$3.20MMay 3, 2026Apr 14, 2028METAGENOMIC NEXT-GENERATION SEQUENCING (MNGS)
    New federal contracts awarded in the 12 months through Jul 31, 2026, largest first. All from the Department of Health and Human Services.

    Monthly Obligations

    The latest complete month, Apr 2026, had no net obligations. The largest month in the table was Aug 2024, at $54.51M.

    MonthObligations
    Jul 2026$0
    Jun 2026$0
    May 2026$3.20M
    Apr 2026$0
    Mar 2026$21M
    Feb 2026$0
    Jan 2026$0
    Dec 2025$0
    Nov 2025$0
    Oct 2025$0
    Sep 2025$1.71M
    Aug 2025$676,131
    MonthObligations
    Jul 2025-$135,434
    Jun 2025$1.12M
    May 2025$0
    Apr 2025$0
    Mar 2025$0
    Feb 2025$68,090
    Jan 2025$54.18M
    Dec 2024-$53.60M
    Nov 2024$0
    Oct 2024$0
    Sep 2024$11.21M
    Aug 2024$54.51M

    Net obligations recorded each month, newest first. Agencies report contract actions with a delay (the Defense Department about 90 days), so the latest months, May to Jul 2026, are still incomplete and the 12-month total usually rises as agencies report the rest.

    Frequently Asked Questions About DNA

    How much does Ginkgo Bioworks Holdings receive in federal contracts?

    Ginkgo Bioworks Holdings had $26.59M in federal contract obligations over the 12 months through Jul 31, 2026, compared with $67.34M in the 12 months before, down 60.5%. Obligations are contract bookings by the awarding agency, not recognized revenue.

    What are Ginkgo Bioworks Holdings' largest government contracts?

    The largest new awards over the 12 months through Jul 31, 2026 were 75D30126F00004, Department of Health and Human Services, $3.20M, started May 3, 2026.

    Which agencies award Ginkgo Bioworks Holdings contracts?

    Department of Health and Human Services was the top awarding agency with 95.8% of obligations over the 12 months through Jul 31, 2026. The records cover 2 agencies.

    What new federal contracts did Ginkgo Bioworks Holdings win in the 12 months through Jul 31, 2026?

    Ginkgo Bioworks Holdings won 1 new federal contract in the 12 months through Jul 31, 2026. The largest was 75D30126F00004, Department of Health and Human Services, $3.20M, started May 3, 2026.

    How do Ginkgo Bioworks Holdings' federal obligations compare with its revenue?

    Federal contract obligations were $26.59M over the 12 months through Jul 31, 2026, equivalent to 17.6% of Ginkgo Bioworks Holdings' revenue. Obligations are amounts the government committed to contracts in the period, not the share of Ginkgo Bioworks Holdings' revenue that comes from the government.